Ethambutol resistance in Mycobacterium tuberculosis: Critical role of embB mutations

Antimicrobial Agents and Chemotherapy

Volumn 41, Issue 8, 1997, Pages 1677-1681

  Sreevatsan, Srinand ^a   Stockbauer, Kathryn E ^a   Pan, Xi ^a   Kreiswirth, Barry N ^b   Moghazeh, Soraya L ^b   Jacobs Jr , William R ^c   Telenti, Amalio ^d   Musser, James M ^a,e  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b PUBLIC HEALTH RESEARCH INSTITUTE   (United States)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^d UNIVERSITY OF BERN   (Switzerland)

^e HOUSTON METHODIST HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL DNA; ETHAMBUTOL; ISOLEUCINE; METHIONINE; VALINE;

AMINO ACID SUBSTITUTION; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; CONTROLLED STUDY; DNA SEQUENCE; DRUG PROTEIN BINDING; GENE MUTATION; MINIMUM INHIBITORY CONCENTRATION; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; NUCLEIC ACID BASE SUBSTITUTION; OPERON; PRIORITY JOURNAL; SINGLE STRAND CONFORMATION POLYMORPHISM; TUBERCULOSIS;

EID: 0030789249     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.41.8.1677     Document Type: Article

References (39)

1. Beggs, W. H., and F. A. Andrews. 1973. Nonspecific inhibition of ethambutol binding by Mycobacterium smegmatis. Antimicrob. Agents Chemother. 4:115-119.
2. Belanger, A. E., G. S. Besra, M. E. Ford, K. Mikusová, J. T. Belisle, P. J. Brennan, and J. M. Inamine. 1996. The embAB genes of Mycobacterium avium encode an arabinosyl transferase involved in cell wall arabinan biosynthesis that is the target for the antimycobacterial drug ethambutol. Proc. Natl. Acad. Sci. USA 93:11919-11924.
3. Bloch, A. B., G. M. Cauthen, I. M. Onaroto, K. G. Dansbury, G. D. Kelly, C. R. Driver, and D. E. Snider. 1994. Nationwide survey of drug-resistant tuberculosis in the United States. JAMA 271:665-671.
4. Bodmer, T., G. Zurcher, P. Imboden, and A. Telenti. 1995. Mutation position and type of substitution in the β-subunit of the RNA polymerase influence in-vitro activity of rifamycin-resistant Mycobacterium tuberculosis. J. Antimicrob. Chemother. 35:345-348.
5. Cohn, D. L., F. Bustreo, and M. C. Raviglione. 1997. Drug-resistant tuberculosis: review of the worldwide situation and the WHO/IUATLD global surveillance project. Clin. Infect. Dis. 24:5121-5130.
6. Cooksey, R. C., G. P. Morlock, A. McQueen, S. E. Glickman, and J. T. Crawford. 1996. Characterization of streptomycin resistance mechanisms among Mycobacterium tuberculosis isolates from patients in New York City. Antimicrob. Agents Chemother. 40:1186-1188.
7. Deng, L., K. Mikusová, K. G. Robuck, M. Scherman, P. J. Brennan, and M. R. McNeil. 1995. Recognition of multiple effects of ethambutol on metabolism of mycobacterial cell envelope. Antimicrob. Agents Chemother. 39:694-701.
8. Finken, M., P. Kirschner, A. Meier, A. Wrede, and E. C. Böttger. 1993. Molecular basis of streptomycin resistance in Mycobacterium tuberculosis: alterations of the ribosomal protein S12 gene and point mutations within a functional 16S ribosomal RNA pseudoknot. Mol. Microbiol. 9:1239-1246.
9. Forbes, M., N. A. Kuck, and E. A. Peets. 1965. Effect of ethambutol on nucleic acid metabolism in Mycobacterium smegmatis and its reversal by polyamines and divalent cations. J. Bacteriol. 89:1299-1305.
10. Gangadharam, P. R., and E. R. Gonzales. 1970. Influence of the medium on the in vitro susceptibility of Mycobacterium tuberculosis to ethambutol. Am. Rev. Respir. Dis. 102:653-655.
11. Heifets, L. B., M. D. Iseman, and P. J. Lindholm-Levy. 1986. Ethambutol MICs and MBCs for Mycobacterium avium complex and Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 30:927-932.
12. Heym, B., N. Honoré, C. Truffot-Pernot, A. Banerjee, C. Schurra, W. R. Jacobs Jr., J. D. A. van Embden, J. H. Grosset, and S. T. Cole. 1994. Implications of multidrug resistance for the future of short-course chemotherapy of tuberculosis: a molecular study. Lancet 344:293-298.
13. Kapur, V., T. S. Whittam, and J. M. Musser. 1994. Is Mycobacterium tuberculosis 15,000 years old? J. Infect. Dis. 170:1348-1349.
14. Kapur, V., L.-L. Li, S. Iordanescu, M. R. Hamrick, A. Wanger, B. N. Kreiswirth, and J. M. Musser. 1994. Characterization by automated DNA sequencing of mutations in the gene (rpoB) encoding the RNA polymerase β subunit in rifampin-resistant Mycobacterium tuberculosis strains from New York City and Texas. J. Clin. Microbiol. 32:1095-1098.
15. Kapur, V., L.-L. Li, M. R. Hamrick, B. B. Plikaytis, T. M. Shinnick, A. Telenti, W. R. Jacobs, Jr., A. Banerjee, S. Cole, K. Y. Yuen, J. E. Clarridge III, B. N. Kreiswirth, and J. M. Musser. 1995. Rapid Mycobacterium species assignment and unambiguous identification of mutations associated with antimicrobial resistance in Mycobacterium tuberculosis by automated DNA sequencing. Arch. Pathol. Lab. Med. 119:131-138.
16. Kilburn, J. O., K. Takayama, E. L. Armstrong, and J. Greenberg. 1981. Effects of ethambutol on phospholipid metabolism in Mycobacterium smegmatis. Antimicrob. Agents Chemother. 19:346-348.
17. Kreiswirth, B. N., and A. Moss. 1996. Genotyping multidrug-resistant M. tuberculosis in New York City, p. 199-209. In W. N. Rom and S. M. Garay (ed.), Tuberculosis. Little, Brown & Company, Boston, Mass.
18. Maddry, J. A., W. J. Suling, and R. C. Reynolds. 1996. Glycosyl transterases as targets for inhibition of cell wall synthesis in Mycobacterium tuberculosis and Mvcobacterium avium. Res. Microbiol. 147:106-112.
19. Meier, A., P. Sander, K.-J. Schaper, M. Scholz, and E. C. Bottger. 1996. Correlation of molecular resistance mechanisms and phenotypic resistance levels in streptomycin-resistant Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 40:2452-2454.
20. Mikusová, K., R. A. Slayden, G. S. Besra, and P. J. Brennan. 1995. Biogenesis of the mycobacterial cell wall and the site of action of ethambutol. Antimicrob. Agents Chemother. 39:2484-2489.
21. Moghazeh, S. L., X. Pan, T. Arain, C. K. Stover, J. M. Musser, and B. N. Kreiswirth. 1996. Comparative antimycobacterial activities of rifampin, rifapentine, and KRM-1648 against a collection of rifampin-resistant Mycobacterium tuberculosis isolates with known rpoB mutations. Antimicrob. Agents Chemother. 40:2655-2657.
22. Morris, S., G. H. Bai, P. Suffys, L. Portillo-Gomez, M. Fairchok, and D. Rouse. 1995. Molecular mechanisms of multiple drug resistance in clinical isolates of Mycobacterium tuberculosis. J. Infect. Dis. 171:954-960.
23. Musser, J. M. 1995. Antimicrobial agent resistance in mycobacteria: molecular genetic insights. Clin. Microbiol. Rev. 8:496-514.
24. Musser, J. M., V. Kapur, D. L. Williams, B. N. Kreiswirth, D. van Soolingen, and J. D. A. van Embden. 1996. Characterization of the catalase-peroxidase gene (katG) and inhA locus in isoniazid-resistant and -susceptible strains of Mycobacterium tuberculosis by automated DNA sequencing: restricted array of mutations associated with drug resistance. J. Infect. Dis. 173:196-202.
25. Nair, J., D. A. Rouse, G. H. Bai, and S. L. Morris. 1993. The rpsL gene and streptomycin resistance in single and multiple drug-resistant strains of Mycobacterium tuberculosis. Mol. Microbiol. 10:521-527.
26. National Committee for Clinical Laboratory Standards. 1990. Antimycobacterial susceptibility testing. Proposed standard M24-P. National Committee for Clinical Laboratory Standards, Villanova, Pa.
27. Ohno, H., H. Koga, S. Kohno, T. Tashiro, and K. Hara. 1996. Relationship between rifampin MICs for and rpoB mutations of Mycobacterium tuberculosis strains isolated in Japan. Antimicrob. Agents Chemother. 40:1053-1056.
28. Paulin, L. G., E. E. Brander, and H. J. Pösö. 1985. Specific inhibition of spermidine synthesis in Mycobacteria spp. by dextro isomer of ethambutol. Antimicrob. Agents Chemother. 28:157-159.
29. Silve, G., P. Valero-Guillen, A. Quemard, M.-A. Dupont, M. Daffe, and G. Laneelle. 1993. Ethambutol inhibition of glucose metabolism in mycobacteria: a possible target of the drug. Antimicrob. Agents Chemother. 37:1536-1538.
30. Sreevatsan, S., and J. M. Musser. 1997. Unpublished data.
31. Srinand, S., The International Working Group, and J. M. Musser. 1996. Molecular population genetics of katG codon 463 and gyrA codon 95 polymorphisms in the Mycobacterium tuberculosis complex (MTC), abstr. U119, p. 122. In Abstracts of the 96th General Meeting of the American Society for Microbiology 1996. American Society for Microbiology. Washington, D.C.
32. Takayama, K., and J. O. Kilburn. 1989. Inhibition of synthesis of arabinogalactan by ethambutol in Mycobacterium smegmatis. Antimicrob. Agents Chemother. 33:1493-1499.
33. Takiff, H. E., L. Salazar, C. Guerrero, W. Philipp, W. M. Huang, B. Kreiswirth, S. T. Cole, W. R. Jacobs, Jr., and A. Telenti. 1994. Cloning and nucleotidc sequence of Mycobacterium tuberculosis gyrA and gyrB genes and detection of quinolone resistance mutations. Antimicrob. Agents Chemother. 38:773-780.
34. Telenti, A., P. Imboden, F. Marchesi, D. Lowrie, S. T. Cole, M. J. Colston, L. Matter, K. Schopfer, and T. Bodmer. 1993. Detection of rifampin-resistance mutations in Mycobacterium tuberculosis. Lancet 341:647-650.
35. Telenti, A., P. Imboden, F. Marchesi, T. Schmidheini, and T. Bodmer. 1993. Direct, automated detection of rifampin-resistant Mycobacterium tuberculosis by polymerase chain reaction and single-strand conformation polymorphism analysis. Antimicrob. Agents Chemother. 37:2054-2058.
36. Telenti, A., W. J. Philipp, S. Sreevatsan, C. Bernasconi, K. E. Stockbauer, B. Wieles, J. M. Musser, and W. R. Jacobs, Jr. 1997. The emb operon, a gene cluster of Mycobacterium tuberculosis involved in resistance to ethambutol. Nature Med. 3:567-570.
37. van Embden, J. D. A., M. D. Cave, J. T. Crawford, J. W. Dale, K. D. Eisenach, B. Gicquel, P. Hermans, C. Martin, R. McAdam, T. M. Shinnick, and P. M. Small. 1993. Strain identification of Mycobacterium tuberculosis by DNA fingerprinting: recommendations for a standardized methodology. J. Clin. Microbiol. 31:406-409.
38. Wolucka, B. A., M. R. McNeil, E. deHoffmann, T. Chojnacki, and P. J. Brennan. 1994. Recognition of the lipid intermediate for arabinan/arabinogalactan biosynthesis and its relation to the mode of action of ethambutol on mycobacteria. J. Biol. Chem. 269:23328-23335.
39. Xu, C., B. N. Kreiswirth, S. Sreevatsan, J. M. Musser, and K. Drlica. 1996. Fluoroquinolone resistance associated with specific gyrase mutations in clinical isolates of multidrug-resistant Mycobacterium tuberculosis. J. Infect. Dis. 174:1127-1130.